Skip to content

An Intervention to Improve Prolapse Using Femmeze® (v1)

An Intervention to Improve the Management of Posterior Vaginal Compartment Prolapse Using Femmeze®: a Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02280382
Acronym
Femmeze®
Enrollment
36
Registered
2014-10-31
Start date
2015-10-31
Completion date
2019-03-31
Last updated
2019-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse, Rectocele

Keywords

splinting

Brief summary

The main purpose of the feasibility study is to identify the patient experience of Femmeze® which is a device aimed at improving posterior vaginal compartment prolapse (rectocele) for women with obstructive defaecation. The investigators want to investigate implementation and preliminary effectiveness of the device. The method of investigation will be a pre-post intervention design, which involves asking 30 women to use Femmeze® over a period of 8 weeks. This is an academic study on a labelled indication (http://www.nres.nhs.uk/search/?q=medical+devices).

Detailed description

Aim Evaluate the feasibility of the Femmeze® device to improve management of posterior vaginal compartment prolapse addressing implementation of the intervention and preliminary effectiveness. Objectives * demonstrate effectiveness of the device (comfort, ease of use, empty the rectum of stool more easily than their current approach and quality of life) * identify which stage of prolapse the device would be most suitable * identify any changes to the device or instructions for use (needs adjustment to its design in terms of length/width) The study will use a pre-post intervention design with the aim of evaluating the feasibility of the intervention (using the device); and identifying any implementation issues and preliminary effectiveness. The participants will be followed prospectively to compare the device against their own usual care. Usual care in this context will be using their fingers to help empty their rectum of stool. Participants will be invited to complete a semi-structured interview to understand their lived experience. A Patient and Public Involvement Group has contributed to improving the study methods.

Interventions

DEVICEFemmeze®

Femmeze will be used by women in the intervention group for 8 weeks These women will be measuring against their usual care in a linear design; measurement will include validated questionnaires

Sponsors

Peninsula Health
CollaboratorOTHER_GOV
Royal Cornwall Hospitals Trust
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult women (over 18 years of age) with symptoms of obstructive defaecation * Not undergone posterior vaginal compartment prolapse surgery

Exclusion criteria

* Cognitive impairment * Hand disability * Refuse to give informed consent * Pregnancy * Less than 12 weeks post-partum * Neurological disease

Design outcomes

Primary

MeasureTime frameDescription
Quality of life instrument (ICIQ-Vaginal Symptoms)12 monthshttp://www.iciq.net/ICIQ-VS.html

Secondary

MeasureTime frameDescription
Device feedback questionnaire12 monthsevaluating the device from the participants perspective

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026